Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwid, S. R.
Right arrow Articles by Cook, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwid, S. R.
Right arrow Articles by Cook, S. D.
Related Collections
Right arrow Clinical trials Methodology/study design
Right arrow Multiple sclerosis
Neurology 2002;58:1294-1296
© 2002 American Academy of Neurology
Brief Communications

Quantitative functional measures in MS: What is a reliable change?

S. R. Schwid, MD, A. D. Goodman, MD, M. P. McDermott, PhD, C. F. Bever, MD and S. D. Cook, MD

From the Departments of Neurology (Drs. Schwid, Goodman, and McDermott) and Biostatistics (Dr. McDermott), University of Rochester Medical Center, NY; Department of Neurology (Dr. Bever), University of Maryland, Baltimore; and Department of Neurology (Dr. Cook), University of Medicine and Dentistry of New Jersey, Newark.

Address correspondence and reprint requests to Dr. Steven R. Schwid, 601 Elmwood Ave., Box 605, Rochester, NY 14642; e-mail: Steven_Schwid{at}urmc.rochester.edu

As a first step toward understanding which changes should be considered as meaningful, the authors assessed the reliability of quantitative functional tests on 5 consecutive days in 63 patients with MS, determining the range of measurement variability present when patients are clinically stable. Time to walk 25 feet (T25FW) and the 9-hole peg test (9HPT) varied by <20% of individual mean scores on repeated testing. Therefore, a 20% change on these tests can be considered to be the threshold that reliably indicates a true change in function for an individual.




This article has been cited by other articles:


Home page
 Mult SclerHome page
R. Rudick, C. Polman, J. Cohen, M. Walton, A. Miller, C Confavreux, F. Lublin, M Hutchinson, P. O'Connor, S. Schwid, et al.
Assessing disability progression with the Multiple Sclerosis Functional Composite
Multiple Sclerosis, August 1, 2009; 15(8): 984 - 997.
[Abstract] [PDF]

Home page
 Mult SclerHome page
L. Bosma, J. Kragt, L Brieva, Z Khaleeli, X Montalban, C. Polman, A. Thompson, M Tintore, and B. Uitdehaag
The search for responsive clinical endpoints in primary progressive multiple sclerosis
Multiple Sclerosis, June 1, 2009; 15(6): 715 - 720.
[Abstract] [PDF]

Home page
 Mult SclerHome page
M. Simeoni, P. Auquier, O. Fernandez, P. Flachenecker, S. Stecchi, C. Constantinescu, E. Idiman, A. Boyko, A. Beiske, T. Vollmer, et al.
Validation of the Multiple Sclerosis International Quality of Life questionnaire
Multiple Sclerosis, March 1, 2008; 14(2): 219 - 230.
[Abstract] [PDF]

Home page
 BrainHome page
V. de Groot, H. Beckerman, B. M. J. Uitdehaag, H. C. W. de Vet, G. J. Lankhorst, C. H. Polman, and L. M. Bouter
The usefulness of evaluative outcome measures in patients with multiple sclerosis
Brain, October 1, 2006; 129(10): 2648 - 2659.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
J J Kragt, F A. van der Linden, J M Nielsen, B M. Uitdehaag, and C H Polman
Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis
Multiple Sclerosis, September 1, 2006; 12(5): 594 - 598.
[Abstract] [PDF]

Home page
 Mult SclerHome page
S J Crenshaw, T D Royer, J G Richards, and D J Hudson
Gait variability in people with multiple sclerosis
Multiple Sclerosis, September 1, 2006; 12(5): 613 - 619.
[Abstract] [PDF]

Home page
 NeurologyHome page
A. Romberg, A. Virtanen, J. Ruutiainen, S. Aunola, S.-L. Karppi, M. Vaara, J. Surakka, T. Pohjolainen, and A. Seppanen
Effects of a 6-month exercise program on patients with multiple sclerosis: A randomized study
Neurology, December 14, 2004; 63(11): 2034 - 2038.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
O.R. Pearson, M.E. Busse, R.W.M. van Deursen, and C.M. Wiles
Quantification of walking mobility in neurological disorders
QJM, August 1, 2004; 97(8): 463 - 475.
[Full Text] [PDF]

Home page
 Mult SclerHome page
C Vaney, S Vaney, and D T Wade
SaGA S, the Short and Graphic A bility Score: an alternative scoring method for the motor components of the Multiple Sclerosis Functional C omposite
Multiple Sclerosis, April 1, 2004; 10(2): 231 - 242.
[Abstract] [PDF]

Home page
 Mult SclerHome page
E L. Hoogervorst, N F Kalkers, G R Cutter, B M. Uitdehaag, and C H Polman
The patient's perception of a (reliable) change in the Multiple Sclerosis Functional C omposite
Multiple Sclerosis, February 1, 2004; 10(1): 55 - 60.
[Abstract] [PDF]

Home page
 NeurologyHome page
B.M. J. Uitdehaag, H.J. Ader, N.F. Kalkers, C.H. Polman, S.R. Schwid, A.D. Goodman, M.P. McDermott, C.F. Bever, and S.D. Cook
Quantitative functional measures in MS: What is a reliable change?
Neurology, August 27, 2002; 59(4): 648 - 649.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by AAN Enterprises, Inc.